Essentials in Stability Analysis and Expiry Determination - The author discusses the need for stability analysis. - BioPharm International

ADVERTISEMENT

Essentials in Stability Analysis and Expiry Determination
The author discusses the need for stability analysis.


BioPharm International
pp. 56-62

CONCLUSION
Stability testing is fundamental to all drug development and manufacturing. All organizations need to have a clear vision of phase appropriate stability study design, organized data collection, strong and appropriate data analysis, clear stability reports with available analytical methods to achieve the product development goals of stable products going to the consumer and the marketplace, and meet all of the regulatory requirements for submission. An integrated approach with clear organizational ownership assures stability testing will add value to all development activities from early formulation, to setting appropriate acceptance limits on lot release.

Thomas A. Little, PhD, is president of Thomas A. Little Consulting in Highland, UT,

REFERENCES
1. ICH, Q1A(R2) Stability Testing of New Drug Substances and Products, 2003.

2. ICH, Q9 Quality Risk Management, 2006.

3. ICH Q8(R2) Pharmaceutical Development, 2009

4. ICH, Q1E Evaluation of Stability Data, 2003.

5. ICH, Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products, 2002.

6. ICH, Q6B Specifications: Test Procedures and acceptance Criteria for Biotechnological/Biological Products, 1999.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here